ugichem's Unattributed VC Round

ugichem raised a round of funding on August 06, 2011.

ugichem is developing antisense drugs based on its proprietary Ugimer platform for unmet medical needs in immune-mediated inflammatory diseases (IMID). Ugimers overcome the shortcomings of standard a…

Articles about ugichem's Unattributed VC Round: